Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | NX-2127 |
Trade Name | |
Synonyms | NX 2127|NX2127 |
Drug Descriptions |
NX-2127 is a small molecule that induces degradation of BTK, which may lead to inhibition of the growth of malignant B-cells (62nd ASH Annual Meeting and Exposition, Dec 2020, Abstract 2788). |
DrugClasses | BTK inhibitor 36 |
CAS Registry Number | NA |
NCIT ID | C180499 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NX-2127 | NX-2127 | 0 | 1 |